References
- Antonini D, Sibilio A, Dentice M, Missero C (2013) An intimate relationship between thyroid hormone and skin: regulation of gene expression. Front Endocrinol. 4:104.
- Ayala C, Valdez SR, Morero ML, Soaje M, Carreño NB, Sanchez MS, Bittencourt JC, Jahn GA, Celis ME (2011) Hypo- and hyperthyroidism affect NEI concentration in discrete brain areas of adult male rats. Peptides. 32:1249–1254.
- Benavides VC, Mallela MK, Booth CJ, Wendler CC, Rivkees SA (2012) Propylthiouracil is teratogenic in murine embryos. PLoS One. 7(4), e35213.
- Buckley KM, Floor E, Kelly R (1987) Cloning and sequence analysis of cDNA encoding p38, a major synaptic vesicle protein. J Cell Biol. 105:2447–2456.
- Burman KD, McKinley-Grant L (2006) Dermatologic aspects of thyroid disease. Clin Dermatol. 24:247–255.
- Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA (1998) Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol. 22:976–982.
- Busam KJ, Jungbluth AA (1999) Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol. 6:12–18.
- Callen JP (2008) Dermatologic manifestations in patients with systemic diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, Eds. Dermatology. 2nd ed. St. Louis (MO): Mosby Elsevier; p. 675–692.
- Coukos G, Makrigiannakis A, Amin K, Albelda SM, Coutifaris C (1998) Platelet-endothelial cell adhesion molecule-1 is expressed by a subpopulation of human trophoblasts: a possible mechanism for trophoblast-endothelial interaction during haemochorial placentation. Mol Hum Reprod. 4:357–367.
- Deftos LJ (1991) Chromogranin A: its role in endocrine function, and as an endocrine and neuroendocrine tumor marker. Endocrinol Rev. 12:181–188.
- Doshi DN, Blyumin ML, Kimball AB (2008) Cutaneous manifestations of thyroid disease. Clin Dermatol. 26:283–287.
- Frienkel RK, Frienkel N (1972) Hair growth and alopecia in hypothyroidism. Arch Dermatol. 106:349–352.
- Fuertes L, Santonja C, Kutzner H, Requena L (2013) Immunohistochemistry in dermatopathology: a review of the most commonly used antibodies (Part I). Acta Dermosifiliogr. 104:99–127.
- Goswami K, Nandakumar DN, Koner BC, Bobby Z, Sen SK (2003) Oxidative changes and desialylation of serum proteins in hyperthyroidism. Clin Chim Acta. 337:163–168.
- Hall JE (2011) Guyton and Hall textbook of medical physiology. 11th ed. Philadelphia (PA): Saunders; p. 11–23.
- Heymann WR (1992) Cutaneous manifestations of thyroid disease. J Am Acad Dermatol. 26:885–902.
- Heymann WR (1997) Advances in cutaneous manifestations of thyroid disease. Int J Dermatol. 36:641–645.
- Jackson DG, Prevo R, Clasper S, Banerji S (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22:317–321.
- Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Brüning T, Creaney J (2017) Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer. 17:386
- Knudsen CB, Knudson W (1993) Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J. 7:1233–1341.
- Luger T, Böhm M (2009) Endocrine diseases. In: Burgdorf W, Plewing G, Wolff HH, Landthaler M, Eds. Braun-Falco’s dermatology. 3rd ed. Heidelberg: Springer Medizin Verlag; p. 1312–1324.
- Luna GL (1968) Manual of histologic staining methods of the armed forces institute of pathology. 3rd ed. New York (NY): McGraw Hill Book Co; p. 32–34.
- Mistry D, Altini M, Coleman HG, Ali H, Maiorano E (2001) The spatial and temporal expression of calretinin in developing rat molars (Rattus norvegicus). Arch Oral Biol. 46:973–981.
- Mostaghni K, Badiei K, Khodakaram-Tafti A, Maafi AB (2008) Pathological and biochemical studies of experimental hypothyroidism in sheep. Vet Arch. 78:209–216.
- Mullin GE, Eastern JS (1986) Cutaneous signs of thyroid disease. Am Fam Phys. 34:93–98.
- Niepomniszcze H, Amad RH (2001) Skin disorders and thyroid diseases. J Endocrinol Invest. 24:628–638.
- O’Connor DT, Deftos LJ (1986) Secretion of chromogranin A by peptide producing endocrine neoplasms. New Engl J Med. 314:1145–1151.
- Puri NA (2012) Study on cutaneous manifestations of thyroid disease. Ind J Dermatol. 57:247–248.
- Safer JD (2011) Thyroid hormone action on skin. Dermato-Endocrinol. 3:211–215
- Safer JD (2013) Thyroid hormone and wound healing. J Thy Res. Article ID 124538.
- Schofield JN, Day IN, Thompson RJ, Edwards YH (1995) PGP9.5, a ubiquitin C-terminal hydrolase: pattern of mRNA and protein expression during neural development in the mouse. Brain Res Dev Brain Res. 85:229–238.
- Sobol RE, Memoli V, Deftos LJ (1989) Hormone-negative, chromogranin A positive endocrine tumors. N Engl J Med. 320:444–447.
- Tacha D (2003) Immunohistochemistry of the skin. Lab Med. 34:311–316.
- Topsakal S, Ozmen O, Ozgocmen M (2019) Effects of alpha-lipoic acid on high fructose induced hepatic pathology. Biotech Histochem. 94:271–276.
- Venditti P, Balestrieri M, Di Meo S, De Leo T (1997) Effect of thyroid state on lipid peroxidation, antioxidant defences and susceptibility to oxidative stress in rat tissues. J Endocrinol. 155:151–157.
- Wiedenmann B, Kahn C, Schwechheimer K, Waldherr R, Raue F, Brandeis WE, Kommerell B, Franke WW (1987) Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting. Am J Clin Pathol. 88:560–569.